INTRODUCTION
============

Zygote and morula stage embryos possess a totipotency for generation of a whole organism. Only cells of the inner cell mass (ICM) from blastocyst have the pluripotent capacity for formation of all three primary germ layers, endoderm, mesoderm, and ectoderm. In adult tissues, multipotent stem and progenitor cells exist in tissues and organs for replacement of lost or injured cells ([@b30-ajas-28-12-1721]). Embryonic stem cells (ESCs) are derived from the ICM in the blastocyst stage embryo and can rise to all cells of the embryo ([@b24-ajas-28-12-1721]). Once established *in vitro*, ESCs can be cultured indefinitely without losing their pluripotency, and have the capacity to develop into any cell type in the body, and self-renewal ([@b21-ajas-28-12-1721]). In addition, development of undifferentiated ESCs occurs *in vitro* via three-dimensional aggregates (embryoid body \[EB\]) into differentiated cell types of all three primary germ layers ([@b13-ajas-28-12-1721]).

The capacity for self-renewal and the pluripotency of ESCs is known to be controlled by the transcription factors, Nanog homeobox (NANOG), octamer binding transcription factor-4 (OCT4) and sex determining region-Y box-2 (SOX2), and signaling pathways like leukemia inhibitory factor (LIF)-signal transducer and activator of transcription 3 (STAT3) and bone morphogenic protein (BMP)-Mothers against decapentaplegic homolog (SMAD) 1/4/5/8 ([@b23-ajas-28-12-1721]). Function and capability of these transcriptional genes and signaling pathways depend on the stage of development of the self-renewal and pluripotent cells, indicating that these factors function in combination with other processes ([@b4-ajas-28-12-1721]). These transcription factors activate repressed pattern of gene expression like GATA binding transcription factor 4/6 (GATA4/6) and caudal type homeobox 2 (CDX), which mediate phenotypic changes toward endoderm during stem cell differentiation, and repress activated pattern of gene expression for differentiation to mesoderm and ectoderm like T-box transcription factor 3 (TBX3) and estrogen-related receptor beta (ESRRB) ([@b1-ajas-28-12-1721]).

Among ESCs transcription factors, *NANOG* is a homeobox-containing a transcription factor with an essential role in maintaining the pluripotent cells of the ICM and ESCs ([@b17-ajas-28-12-1721]). It is expressed in pluripotent cells and is absent from differentiated cells. Both *NANOG* and *OCT4* promoter-driven enhanced green fluorescent protein (EGFP) have been monitored in undifferentiated state ESCs, but not detected following differentiation ([@b6-ajas-28-12-1721]). Disruption of *NANOG* in ESCs results in differentiation to endoderm lineages ([@b12-ajas-28-12-1721]), while over-expression of *NANOG* in mouse ESCs renders LIF dependent ESCs self-renewal, although the self-renewal capacity of the cells is reduced, suggesting that *NANOG* is a major regulator of the pluripotent state. The *NANOG* over-expression effect is neither dependent on STAT3 activation nor requires presence of BMP4 ([@b17-ajas-28-12-1721]). However, little is known about regulation of *NANOG* gene expression with various transcriptional regulators.

So far, validated ESC lines that can contribute to the germline in chimeras have only been established in mice, rats, and chickens ([@b19-ajas-28-12-1721]; [@b2-ajas-28-12-1721]; [@b16-ajas-28-12-1721]). While ESC lines have also been established in other species, they have not been fully validated due to either ethical reasons in the case of human ([@b28-ajas-28-12-1721]) or technical reasons in the case of mink ([@b25-ajas-28-12-1721]), hamster ([@b5-ajas-28-12-1721]), rhesus monkey (Thompson et al., 1995), canine ([@b9-ajas-28-12-1721]; [@b10-ajas-28-12-1721]), and various large domestic species. Bovine induced pluripotent stem cells (iPSCs) and ESC-like cells have been established, but not maintained long-term ([@b14-ajas-28-12-1721]; [@b11-ajas-28-12-1721]; [@b26-ajas-28-12-1721]). For these reasons, the molecular characteristics of *NANOG* from domestic animals including bovine have not yet been fully determined. The bovine *NANOG* promoter sequences (−420/+181) were isolated and their promoter activity was examined in mouse ESCs as a heterologous system. In transfection study, the bovine *NANOG* promoter exhibited strong activity in mouse ESCs as a heterologous system and its promoter activity was down-regulated during ESCs differentiation, suggesting that *NANOG* promoter activity is conserved across the mammalian species and bovine *NANOG* promoter will be useful in development of bovine ESCs.

MATERIALS AND METHODS
=====================

Isolation of bovine *NANOG* 5′-flanking region and construction of bovine *NANOG* promoter-green fluorescent protein reporter recombinant plasmid
-------------------------------------------------------------------------------------------------------------------------------------------------

Bovine genomic DNA was isolated from ear cells of Korean beef cattle using the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA). The bovine *NANOG* promoter region was amplified from the +181 bp region (anti-sense primer: 5′-CTGCTTGCTCACCAT GTTGCTGAGTTGAAGGAG-3′) to the −420 bp region (sense primer: 5′-CCGGAAGCTTAAAGAGGAAAAT GGAGTTAG-3′). Polymerase chain reaction (PCR) amplification was performed using 10 ng of genomic DNA template in final volumes of 50μL using AccuPower *Pfu* PCR PreMix (Bioneer, Daejeon, Korea). The PCR conditions were as follows: 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 64°C for 45 s, extension at 72°C for 1 min, and the final extension step was prolonged to 5 min. The PCR product was digested with *Hin*dIII (TAKARA, Shiga, Japan) and sticky/blunt ligated into the *Eco*RV and *Hin*dIII site of p*hrGFP II-C* (Agilent Technologies Genomics, Santa Clara, CA, USA) using a ligase kit (ELPIS, Daejeon, Korea).

Cell culture and transgenic cell line
-------------------------------------

Mouse ESC lines (R1) were cultured on inactivated mouse primary embryonic fibroblast feeder cells with mitomycin C (Sigma, St. Louis, MO, USA) and grown in Dulbecco's Modified Eagle's Medium (DMEM) (Gibco, USA), 15% fetal calf serum (HyClone, Logan, UT, USA), 0.1 mM 2-mercaptoethanol (Gibco, USA), 1% non-essential amino acids (Gibco, USA), 2 mM L-glutamine (Gibco, USA), 1 mM MEM sodium pyruvate solution (Gibco, USA), 1% penicillin/streptomycin (Gibco, USA), and 1,000 U/mL LIF (ES-GRO, Chemicon, Billerica, MA, USA). Cells were maintained at 37°C with 5% CO~2~. Recombinant plasmids of mouse *NANOG* (−332/+50) and human *NANOG* (−380/+24) tagged with pEGFP-N1 as an expression reporter were generously donated by Dr. Takashi Tada, Laboratory of Stem Cell Engineering at Kyoto University (Kyoto, Japan). Mouse, human, and bovine *NANOG* promoter-GFP reporter vectors were linearized, and each 4.7 kb, 4.5 kb, and 4.6 kb transgene was electroporated into 1×10^7^ R1 cells at 1,400 V, 10 ms, and pulse number 3 using a Neon Transfection System (Life Technologies, Grand Island, NY, USA). After positive selection with G418 (Sigma, USA) for 1 week, integration of the transgenes in the genome of ESC was assessed by fluorescence with an FITC filter.

Neural differentiation
----------------------

For differentiation, mouse embryonic fibroblasts (MEF) from ESC culture were removed using 0.1% gelatin coated 10 cm petri dishes. MEF free ESCs were cultured in aggregated EBs. Mouse ESCs were cultured in EB formation medium in the absence of LIF in a non-adhesive 10 cm petri dish for 4 days by suspension of 2\~3×10^6^ MEF free ESCs. More directed differentiation of ESCs to the neuronal lineage occurred upon addition of 0.5 μM all-*trans*-retinoic acid (RA, Millipore, Billerica, MA, USA) to the culture for an additional 4 days. Neural induced EBs were subsequently transferred to poly-L-ornithine (10 mg/mL, Millipore, USA) and laminin (1 mg/mL, Millipore, USA) coated slides and cultured in EB formation medium for an additional 8 days. Medium was changed every two days.

Adipocyte differentiation
-------------------------

MEF free mouse ESCs were cultured in EB formation medium in a non-adhesive 10 cm petri dish for 2 days in the absence of LIF to help in formation of EBs. More directed differentiation of ESCs to the adipocyte lineage occurred upon the addition of 0.1 μM RA to the culture for an additional 3 days. Induced EBs were subsequently transferred to 0.1% gelatin coated wells and cultured in freshly prepared adipocyte differentiation medium including 20 nM 3, 3′, 5-triiodo-L-thyronine (T3) solution and 850 nM insulin solution (Millipore, USA) in the EB formation medium for an additional 21 days. Medium was changed every two days.

Immunofluorescence staining
---------------------------

Monolayer cultures of differentiated cells were rinsed with phosphate-buffered saline (PBS) and incubated for 10 min at room temperature in PBS (pH7.4) containing 4% paraformaldehyde. After each of three rinses with PBS and 5% normal donkey serum (Abcam, Cambridge, MA, USA) in PBS, the cells were blocked for 2 h at room temperature with PBS containing 5% donkey serum and 0.3% Triton X-100. The cells were then incubated with mouse NESTIN (1:200), mouse C/EBPβ (1:100) (Abcam, USA) primary antibodies in blocking solution at 4°C overnight. After each of three rinses with PBS and blocking solution, the cells were incubated in blocking solution for 30 min at room temperature. After incubation of the cells in blocking solution with donkey anti-mouse IgG Cy3 conjugated secondary antibody (1:500) (Millipore, USA) for 2 h at room temperature in the dark, the cells were washed with PBS. Finally, the cells were counterstained with 4′,6-diamidino-2-phenylindole (DAPI)(1 μg/mL) (Invitrogen, Waltham, MA, USA), and images were acquired using a LSM 510 META Confocal Laser Scanning Microscope.

Western blot analysis
---------------------

The cells were harvested and lysed at 4°C in radioimmunoprecipitation assay buffer and 100× protease inhibitor cocktail (Thermo Scientific, Waltham, MA, USA) for 1h. The lysate was centrifuged at 14,000 rpm, 30 min at 4°C. The total protein concentration was quantified using a Pierce BCA protein assay kit (Thermo Scientific, USA). Cell extracts (30 μg/lane) were separated by 12% polyacrylamide by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) membranes using an iBlot transfer device (Invitrogen, USA). After blocking with 5% skimmed milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 1.5 h, the membranes were incubated with anti-hrGFP (1:1,000 dilution, Stratagene), anti-EGFP (1:1,000, Clontech), and anti-β actin (1:1,000, Cell Signaling) primary antibodies in TBST overnight at 4°C. After washing with TBST, the membranes were incubated with rabbit horseradish peroxidase-conjugated secondary antibody (1:1,000) and mouse horseradish peroxidase-conjugated secondary antibody (1:1,000) (cell signaling) for 90 min. Hybridization signals were detected using a Super Signal West Pico Chemiluminescent Substrate kit (Thermo Scientific, USA). Density of each protein was determined using the BIO-PROFIL Bio-1D ver.99.04 program. GFP expression was normalized by β-actin at each time point to monitor the *NANOG* promoters activity during differentiation into either adipocyte or neuronal lineages.

RESULTS
=======

Establishment of green fluorescent protein positive transgenic cell line
------------------------------------------------------------------------

To establish the transgenic cell lines of the GFP reporter system tracing expressions of bovine *NANOG* promoter (−420/+181), mouse *NANOG* promoter (−332/+50) and human *NANOG* promoter (−380/+24), linear forms of cytomegalovirus (CMV) promoterless recombinant plasmids were integrated into genomic DNA of mouse R1 ESCs by electroporation. After neomycin positive selection, each positive transgenic ESC line was verified for GFP expression by confocal fluorescence microscopy. Bovine *NANOG*-*GFP* transgenic mouse ESC line expressed a strong level of GFP. Similarly, strong levels of GFP expression were observed in mouse and human *NANOG* transgenic cell lines ([Figure 1](#f1-ajas-28-12-1721){ref-type="fig"}).

Down-regulation of bovine *NANOG* gene during neural differentiation for 16 days
--------------------------------------------------------------------------------

To determine whether *NANOG*-*GFP* transgene expression was down-regulated in mouse ESC differentiation, we examined *NANOG*-*GFP* transgene expression during differentiation toward neurons for 16 days without MEF and LIF. Down-regulation of bovine *NANOG* was detected by both fluorescence microscopy ([Figure 2A](#f2-ajas-28-12-1721){ref-type="fig"}) and western blot analysis ([Figure 2D](#f2-ajas-28-12-1721){ref-type="fig"}). Neuron precursor marker NESTIN was detected from differentiated adhesive cells, but GFP expression was not detected on day 16. On day 8 after RA induction for neural differentiation, the level of GFP expression was decreased by approximately 66% compared with that of day 0. Significantly down-regulated expression of mouse and human *NANOG* as reflected by GFP expression was also observed on day 8 of neuron differentiation by fluorescence microscopy ([Figures 2B and 2C](#f2-ajas-28-12-1721){ref-type="fig"}) and Western blot ([Figures 2E and 2F](#f2-ajas-28-12-1721){ref-type="fig"}). Mouse and human *NANOG*-GFP expression was decreased by approximately 71% and 66%, respectively, on day 8 of neuron differentiation when compared with GFP expression on day 0. The expression patterns of the bovine *NANOG* during neural differentiation were similar to those of mouse and human *NANOG* ([Table 1](#t1-ajas-28-12-1721){ref-type="table"}).

Down-regulation of bovine NANOG during adipocyte differentiation for 26 days
----------------------------------------------------------------------------

To determine whether *NANOG-GFP* transgene expression was down- regulated during differentiation of another cell type, GFP expression was monitored during the differentiation of adipocytes for 26 days without MEF and LIF. Down-regulation of bovine *NANOG* was detected by both fluorescence microscopy ([Figure 3A](#f3-ajas-28-12-1721){ref-type="fig"}) and Western blot analysis ([Figure 3D](#f3-ajas-28-12-1721){ref-type="fig"}). Adipocyte marker C/EBPβ was detected from differentiated adhesive cells, but GFP expression was undetectable on day 26. As expected, bovine *NANOG* expression was gradually reduced during adipogenesis. In particular, 53% decrease was observed on day 5 by induction of RA for 3 days on 2-day-old EB when compared with GFP expression on day 0. In addition, the expression of GFP driven by mouse and human *NANOG* promoter was decreased by approximately 53% and 58%, respectively, on day 5, compared with GFP expression on day 0, as observed by both fluorescence microscopy ([Figures 3B and 3C](#f3-ajas-28-12-1721){ref-type="fig"}) and western blot ([Figures 3E and 3F](#f3-ajas-28-12-1721){ref-type="fig"}). The expression levels of GFP driven by the bovine *NANOG* promoter were comparable with those of GFP expression by both human and murine *NANOG* promoters ([Table 2](#t2-ajas-28-12-1721){ref-type="table"}).

DISCUSSION
==========

The critical features of ESCs provide an invaluable tool for studies related to developmental regulation, functional of genomics, and generation of gene manipulated animals ([@b8-ajas-28-12-1721]). *NANOG* is a crucial transcriptional factor for maintenance of pluripotency in mammalian embryos and ESCs ([@b29-ajas-28-12-1721]). *NANOG* expression is restricted to pluripotent cells and is down-regulated upon differentiation ([@b18-ajas-28-12-1721]). Therefore, understanding the action of *NANOG* expression in maintaining pluripotency and undifferentiated state of ESCs is important. Unfortunately, efforts made to establish validated bovine ESC lines have been fruitless ([@b3-ajas-28-12-1721]). Therefore, further improvements may be needed for studies on bovine development. In this study, we examined the function of bovine *NANOG* promoter using mouse ESCs. To determine whether the bovine *NANOG* gene promoter would have transcriptional activity in mouse ESCs, the construct of the 5′-flanking region of the bovine *NANOG* promoter (−420/+181) was transfected with hrGFP into mouse ESCs and neomycin resistant clones were selected and used for further study. Expression of bovine *NANOG* gene reflected by GFP expression in mouse ESCs was comparable with mouse and human *NANOG* gene promoter driven EGFP. This result demonstrates that the mechanism underlying transcriptional regulation might be conserved across the mammalian species. A previous study reported that the mouse and human *NANOG* promoter regions were capable of expressing GFP reporter construct in both mouse and human ESCs, and differentiation by chemical inducers such as retinoic acid decreased transcriptional activity of *NANOG* promoters. This phenomenon was also observed in another study, where treatment with 0.1 μM RA for 3 days resulted in drastically reduced EGFP tagged mouse *NANOG* protein expression ([@b23-ajas-28-12-1721]). In the same study, FACS analysis indicated that mouse *NANOG* expression was reduced by 50% at 4 days of EB formation, and treatment with 0.1 μM RA for 4 days resulted in 88% reduction of *NANOG* expression as well ([@b23-ajas-28-12-1721]).

As in previous studies ([@b15-ajas-28-12-1721]; [@b23-ajas-28-12-1721]), in our study, GFP expression driven by mouse, human, and bovine *NANOG* promoters was down-regulated by 26%, 22%, and 19%, respectively, at 4 days of neural differentiation, and by 20%, 4%, and 10%, respectively, at 2 days of adipocyte differentiation. In addition, mouse, human, and bovine *NANOG* gene expression showed more rapid down-regulation at 4 days of 0.5 μM RA induced neural differentiation (46%, 45%, and 47%, respectively) and at 2 days of 0.1 μM RA induced adipocyte differentiation (34%, 54%, and 46%, respectively). Exposure of growing EBs to high-RA is known to markedly increase the rate of neural differentiation, whereas exposure to low-RA induces more mesodermal cells like adipocytes ([@b22-ajas-28-12-1721]). Higher concentrations of RA promote more rapid differentiation of ESCs, as indicated by the pattern of OCT4 expression, which was down-regulated more rapidly in EBs exposed to high-RA ([@b20-ajas-28-12-1721]). In addition, *OCT4* and *NANOG* expressions were directly repressed by GCNF during ESCs differentiation when induced by RA ([@b7-ajas-28-12-1721]). GCNF, a transcriptional repressor, down-regulates target gene expression. Therefore, these results indicate that the mechanism for repression of *NANOG* expression in bovine *NANOG* during RA-induced differentiation may also be mediated by GCNF, however further study is warranted for investigation of molecular mechanisms for the conservation of transcriptional regulation of *NANOG* transcription during differentiation.

Conclusion
----------

In this study, we report that the bovine *NANOG* 5′-flanking region from −420 to +181 has an essential role in *NANOG* transcriptional activity, which is important for maintenance of ESCs pluripotency. Therefore, this system has a potential impact on trace *NANOG* expression during bovine embryonic development and will contribute to establishment of bovine ESC lines in *in vitro* cultures using this construct as a potential marker for pluripotency.

This work was supported by a grant from the Next-Generation BioGreen 21 Program (Project No. PJ01109301), Rural Development Administration, Republic of Korea and Inha University Research Grant (INHA-50486).

**CONFLICT OF INTEREST**

We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

![GFP positive transgenic cell lines. Fixed cells were detected under FITC and DAPI filters using a confocal microscope. (A) Bovine *NANOG* promoter-GFP transgenic mouse ESCs. (B) Mouse *NANOG* promoter-GFP transgenic mouse ESCs. (C) Human *NANOG* promoter-GFP transgenic mouse ESCs. Original magnification ×200. (a) Bright field, (b) FITC, (c) DAPI, (d) merge FITC and DAPI.](ajas-28-12-1721f1){#f1-ajas-28-12-1721}

![Down-regulation of GFP expression from GFP positive transgenic cell lines during neuron differentiation. (A--C) Morphological change and GFP expression of differentiated EB cells from bovine, mouse, and human *NANOG* transgenic ESC lines for 16 days of neural differentiation (original magnification ×100), and immunofluorescence staining of differentiated adhesive cells on day 16 with NESTIN antibody (original magnification ×200). (a,c,e) Bright field, (b,d,f) DAPI, g: merge Rodamine and DAPI. (D--F) Each GFP expression was detected by western blot on day 0, 4, 8, and 16.](ajas-28-12-1721f2){#f2-ajas-28-12-1721}

![Down-regulation of GFP from GFP positive transgenic cell lines during adipocyte differentiation. (A--C) Morphological change and GFP expression of differentiated EB cells from bovine, mouse, and human *NANOG* transgenic ESC lines for 26 days of adipocyte differentiation (original magnification ×100), and immunofluorescence staining of differentiated adhesive cells on day 26 with C/EBPβ antibody (original magnification ×200). (D--F) Each GFP expression was detected by western blot on day 0, 2, 5, and 26.](ajas-28-12-1721f3){#f3-ajas-28-12-1721}

###### 

Densities of proteins during neuron differentiation

  Neuron differentiation   Bovine *NANOG*/β-Actin[\*](#tfn1-ajas-28-12-1721){ref-type="table-fn"}   Mouse *NANOG*/β-Actin[\*](#tfn1-ajas-28-12-1721){ref-type="table-fn"}   Human *NANOG*/β-Actin[\*](#tfn1-ajas-28-12-1721){ref-type="table-fn"}
  ------------------------ ------------------------------------------------------------------------ ----------------------------------------------------------------------- -----------------------------------------------------------------------
  Day 0                    66.00 (100%)                                                             56.86 (100%)                                                            67.45 (100%)
  Day 4                    53.63 (81.26%)                                                           42.21 (74.24%)                                                          53.24 (78.93%)
  Day 8                    22.68 (34.37%)                                                           16.25 (28.58%)                                                          22.65 (33.58%)
  Day 16                   0 (0%)                                                                   0 (0%)                                                                  0.00 (0%)

Expression of GFPs were normalized β-actin level. Protein bands were quantified as described in Methods and Materials. After quantification, the values of GFP bands were divided by those of β-actin.

###### 

Densities of proteins during adipocyte differentiation

  Adipocyte differentiation   Bovine *NANOG*/β-Actin[\*](#tfn2-ajas-28-12-1721){ref-type="table-fn"}   Mouse *NANOG*/β-Actin[\*](#tfn2-ajas-28-12-1721){ref-type="table-fn"}   Human *NANOG*/β-Actin[\*](#tfn2-ajas-28-12-1721){ref-type="table-fn"}
  --------------------------- ------------------------------------------------------------------------ ----------------------------------------------------------------------- -----------------------------------------------------------------------
  Day 0                       59.53 (100%)                                                             55.97 (100%)                                                            67.79 (100%)
  Day 4                       53.69 (90.19%)                                                           44.89 (80.20%)                                                          65.14 (96.10%)
  Day 8                       27.80 (46.70%)                                                           26.18 (46.77%)                                                          28.57 (42.15%)
  Day 16                      0 (0%)                                                                   0 (0%)                                                                  0 (0%)

Expression of GFPs were normalized β-actin level. Protein bands were quantified as described in Methods and Materials. After quantification, the values of GFP bands were divided by those of β-actin.
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